- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Robert Gluckman Discusses Relationship Between Pharmacists and Medicine
Robert Gluckman, MD, MACP, from Providence Health Plan, spoke about how medicine and pharmacist interaction can be cost-effective.
In an interview regarding the Newport Beach Institute for Value Based Medicine® conference, Robert Gluckman, MD, MACP, chief medical officer, Providence Health Plan, talked about what he wanted the key takeaways to be as well as how Providence Health Plan reduces cost in medicine and pharmacist interactions.
Transcript
What do you think the role of Providence Health Plan is in making medicine and pharmacist interactions cost-effective?
So one of the things we've done at Providence Health Plan has actually helped support providers, especially primary care practices, with embedded pharmacists. So that can help facilitate ensuring that providers are prescribing effective care, but also informing those providers around payer policy, so that we can reduce the abrasion around denials and make sure that patients can get the care they need as quickly as possible.
What do you want attendees to take away from the IVBM?
I think the biggest thing I wanted people to take away is there is so much opportunity and benefit for the new advances that pharmacy is bringing to the market. And at the same time, we also have this incredible responsibility on how to make things affordable for people. It's going to take a lot of creativity to think about how we're able to bring some of these really important advances but do it in a way that's responsible for society.
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
